Dupuytren Contracture Clinical Trial
Official title:
Efficacy of Post-contracture Release Radiation for the Treatment of Dupuytren's Disease
To determine if the clinical impression of clinicians, ie that patients are improving with the current treatment pathway for Dupuytren's (contracture release followed by radiation), can be substantiated with scientific evidence.
This is an observational, pilot study. Participants will be treated according to a standard treatment pathway, which includes contracture release treatment modalities such as limited fasciectomy, PNA and CCH injection, followed by post-operative radiation. All enrolled participants will undergo radiation treatment as soon as possible following contracture release. Radiotherapy will consist of 5 daily treatments of 300 cGy delivered to the palmar area followed by a 6-8 weeks break then a second 5 day course of radiation at 300 cGy, for a total of 3000 cGy in 10 total fractions. This dosing schedule is commonly used in the published literature. The data to be collected about participants, is their Southampton Dupuytren's score, history and clinical symptoms and photographs of their hand. This information will be obtained at baseline (pre-surgical intervention), at radiation treatment planning, approximately 6 weeks after completion of all radiation and at 1 and 2 years following completion of radiotherapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03155854 -
The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring
|
N/A | |
| Active, not recruiting |
NCT03192020 -
Trial Comparing Treatment Strategies in Dupuytren's Contracture
|
Phase 4 | |
| Recruiting |
NCT05300893 -
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
|
N/A | |
| Completed |
NCT02647619 -
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
|
Phase 4 | |
| Recruiting |
NCT01184586 -
Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)
|
Phase 2 | |
| Withdrawn |
NCT01776892 -
Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease
|
Phase 3 | |
| Completed |
NCT02983162 -
Is wGRS Associated With DD Recurrence?
|
||
| Completed |
NCT01923103 -
Natural Disease Progress of Dupuytren Disease
|
||
| Enrolling by invitation |
NCT03982719 -
Comparing the Effectiveness of Two Post-fasciectomy Rehabilitation Protocols in Patients With Dupuytren's Disease
|
N/A | |
| Not yet recruiting |
NCT04907812 -
The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery
|
Phase 4 | |
| Withdrawn |
NCT03031080 -
BOND Study: the Benefit Of Night Splinting in Dupuytrens'
|
N/A | |
| Completed |
NCT04874870 -
Effectiveness of Splinting After Collagenase Injection
|
Phase 3 | |
| Active, not recruiting |
NCT03407820 -
Different Sutures in Hand Surgery
|
N/A | |
| Recruiting |
NCT03000114 -
Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease
|
Phase 4 | |
| Recruiting |
NCT05440240 -
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
|
Phase 4 | |
| Completed |
NCT03331926 -
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
|
||
| Active, not recruiting |
NCT03741764 -
Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device
|
N/A | |
| Completed |
NCT01876498 -
Registry of Patient With M. Dupuytren and Validation of the Brief MHQ
|
N/A | |
| Completed |
NCT03868449 -
Question Prompt List for Common Hand Conditions
|
N/A | |
| Completed |
NCT03573765 -
Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data
|